These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2012993)
1. Levamisole and the new era of chemoimmunotherapy. Greenspan EM; Erlich R Cancer Invest; 1991; 9(1):111-24. PubMed ID: 2012993 [No Abstract] [Full Text] [Related]
3. Design of phase-I trials of immunopotentiators for cancer therapy: levamisole and Corynebacterium parvum. Hirshaut Y; Pinsky CM; Wanebo HJ; Oettgen HF Ann N Y Acad Sci; 1976; 277(00):252-9. PubMed ID: 793480 [No Abstract] [Full Text] [Related]
9. Effects of levamisole treatment in cancer patients. Amery WK; Verhaegen H J Rheumatol Suppl; 1978; 4():123-35. PubMed ID: 366137 [TBL] [Abstract][Full Text] [Related]
10. Chemoimmunotherapy with levamisole in acute lymphoblastic leukemia. Pavlovsky S; Muriel FS; Garay G; Svarch E; Braier J; Lagarde M; Scaglione C; Eppinger-Helft M; Failace R; Dibar E Cancer; 1981 Oct; 48(7):1500-7. PubMed ID: 7026018 [TBL] [Abstract][Full Text] [Related]
11. Levamisole: a synthetic immunopotentiator under evaluation. Hadden JW Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182 [No Abstract] [Full Text] [Related]
12. Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors--a double-blind randomized trial. Focan C; Schyns-Mosen J; Focan-Henrard D Acta Oncol; 1989; 28(1):105-6. PubMed ID: 2650718 [No Abstract] [Full Text] [Related]
13. Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer. Stevenson HC; Green I; Hamilton JM; Calabro BA; Parkinson DR J Clin Oncol; 1991 Nov; 9(11):2052-66. PubMed ID: 1941064 [TBL] [Abstract][Full Text] [Related]
15. [Selected aspects of levamisole use in oncological clinical practice]. Pawlicki M; Stryjewska B; Zarska M Nowotwory; 1979; 29(4):245-51. PubMed ID: 537926 [No Abstract] [Full Text] [Related]
16. Letter: Levamisole and the immune response. N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358 [No Abstract] [Full Text] [Related]
17. Levamisole, the story and the lessons. Amery WK; Bruynseels JP Int J Immunopharmacol; 1992 Apr; 14(3):481-6. PubMed ID: 1618599 [TBL] [Abstract][Full Text] [Related]
18. Levamisole in the treatment of cancer: anything new? (Review). De Brabander M; De Crée J; Vandebroek J; Verhaegen H; Janssen PA Anticancer Res; 1992; 12(1):177-87. PubMed ID: 1567166 [TBL] [Abstract][Full Text] [Related]
19. Letter: Levamisole in the treatment of cancer. Ward HW Lancet; 1976 Mar; 1(7959):594-5. PubMed ID: 55877 [No Abstract] [Full Text] [Related]
20. Chemoimmunotherapy with levamisole during maintenance therapy in children with acute lymphoblastic leukemia. Bogusławska-Jaworska J; Raus Z Arch Immunol Ther Exp (Warsz); 1981; 29(6):719-23. PubMed ID: 6960810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]